Associations of HLA‐C*01:02 and HLA‐B*46:01 with regorafenib‐induced erythema multiforme in Japanese patients with metastatic colorectal cancer

• Váldodahkkit: Ken‐ichi Fujita (Dahkki), Natsumi Matsumoto (Dahkki), Remi Murase (Dahkki), Kosuke Takeshima (Dahkki), Hiroo Ishida (Dahkki), Yutaro Kubota (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2023-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Regorafenib improves the survival of patients with metastatic colorectal cancer (mCRC); however, it is also characterized by detrimental dermal side effects that may require treatment cessation or modified dosing. In our previous prospective pharmacokinetic, pharmacodynamic, and pharmacogen...